Shandong Polymer Biochemicals Co., Ltd. (SHE:002476)
China · Delayed Price · Currency is CNY 5.04
-0.16 (-3.08%)
Jun 10, 2026, 3:04 PM CST
SHE:002476 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 701.34 | 601.74 | 536.9 | 385.16 | 590.28 | 529.73 |
Other Revenue | 1.55 | 1.55 | 1.76 | 2.17 | 2.01 | 127.43 |
| 702.89 | 603.29 | 538.66 | 387.34 | 592.28 | 657.16 | |
Revenue Growth (YoY) | 32.14% | 12.00% | 39.07% | -34.60% | -9.87% | 46.91% |
Cost of Revenue | 588.98 | 497.71 | 441.45 | 322.27 | 463.09 | 557.07 |
Gross Profit | 113.91 | 105.58 | 97.21 | 65.07 | 129.19 | 100.09 |
Selling, General & Admin | 60.77 | 58.83 | 58.71 | 68.26 | 71.92 | 51.87 |
Research & Development | 19.55 | 18.07 | 20.39 | 17.98 | 25.49 | 22.4 |
Other Operating Expenses | 1.61 | 2.55 | 0.83 | 4.37 | 5.14 | 4.26 |
Operating Expenses | 84.23 | 79.08 | 81.08 | 83.88 | 104.37 | 80.41 |
Operating Income | 29.68 | 26.5 | 16.13 | -18.81 | 24.82 | 19.68 |
Interest Expense | -1.13 | -1.45 | -0.93 | -0.64 | -0.48 | -4.75 |
Interest & Investment Income | 5.2 | 8.78 | 50.13 | 6.05 | 6.68 | 5.38 |
Currency Exchange Gain (Loss) | -0.34 | -0.34 | 1.01 | 1.68 | 5.06 | -0.6 |
Other Non Operating Income (Expenses) | 2.17 | 3.15 | -11.23 | -2.8 | -0.14 | -0.49 |
EBT Excluding Unusual Items | 35.59 | 36.64 | 55.11 | -14.51 | 35.94 | 19.23 |
Gain (Loss) on Sale of Investments | - | - | - | -1.33 | -8.02 | -2.59 |
Gain (Loss) on Sale of Assets | -0.01 | -0.01 | 0.73 | 25.22 | 1.11 | -0.14 |
Asset Writedown | -2.52 | -2.58 | -0.71 | -0 | - | -0.32 |
Other Unusual Items | 2.8 | 2.8 | 6.65 | 1.26 | 2.04 | 1.52 |
Pretax Income | 35.87 | 36.86 | 61.78 | 10.64 | 31.08 | 17.7 |
Income Tax Expense | 5.82 | 5.54 | 5.38 | 5.4 | 1.37 | -0.25 |
Earnings From Continuing Operations | 30.05 | 31.32 | 56.39 | 5.23 | 29.7 | 17.95 |
Net Income | 30.05 | 31.32 | 56.39 | 5.23 | 29.7 | 17.95 |
Net Income to Common | 30.05 | 31.32 | 56.39 | 5.23 | 29.7 | 17.95 |
Net Income Growth | -52.54% | -44.46% | 977.59% | -82.38% | 65.49% | 36.15% |
Shares Outstanding (Basic) | 612 | 612 | 612 | 609 | 612 | 613 |
Shares Outstanding (Diluted) | 612 | 612 | 612 | 609 | 612 | 613 |
Shares Change (YoY) | -0.12% | -0.10% | 0.62% | -0.64% | -0.02% | -0.10% |
EPS (Basic) | 0.05 | 0.05 | 0.09 | 0.01 | 0.05 | 0.03 |
EPS (Diluted) | 0.05 | 0.05 | 0.09 | 0.01 | 0.05 | 0.03 |
EPS Growth | -52.48% | -44.41% | 970.93% | -82.27% | 65.53% | 36.28% |
Free Cash Flow | -75.7 | 4.71 | 24.59 | 114 | -93.18 | -54.04 |
Free Cash Flow Per Share | -0.12 | 0.01 | 0.04 | 0.19 | -0.15 | -0.09 |
Dividend Per Share | - | - | 0.010 | 0.010 | - | - |
Gross Margin | 16.21% | 17.50% | 18.05% | 16.80% | 21.81% | 15.23% |
Operating Margin | 4.22% | 4.39% | 3.00% | -4.86% | 4.19% | 3.00% |
Profit Margin | 4.28% | 5.19% | 10.47% | 1.35% | 5.01% | 2.73% |
Free Cash Flow Margin | -10.77% | 0.78% | 4.57% | 29.43% | -15.73% | -8.22% |
EBITDA | 46.43 | 43.93 | 36.29 | 3.98 | 57.91 | 53.19 |
EBITDA Margin | 6.60% | 7.28% | 6.74% | 1.03% | 9.78% | 8.09% |
D&A For EBITDA | 16.74 | 17.43 | 20.16 | 22.79 | 33.09 | 33.51 |
EBIT | 29.68 | 26.5 | 16.13 | -18.81 | 24.82 | 19.68 |
EBIT Margin | 4.22% | 4.39% | 3.00% | -4.86% | 4.19% | 3.00% |
Effective Tax Rate | 16.23% | 15.03% | 8.71% | 50.80% | 4.42% | - |
Revenue as Reported | 702.89 | 603.29 | 538.66 | 387.34 | 592.28 | 657.16 |
Advertising Expenses | - | 0.41 | 0.29 | 2.65 | 2.47 | - |